I am pleased to share my latest article published by Forbes Business Council. The article discusses why artificial intelligence in genomic medicine should not be driven only by hype or technical excitement, but by strong governance, institutional responsibility, ethical safeguards, and careful clinical adoption. Read the full article here: https://www.forbes.com/councils/forbesbusinesscouncil/2026/05/07/ai-in-genomic-medicine-is-advancing-but-institutions-need-governance-not-

I am pleased to share my academic paper published in Intelligence-Based Medicine, available through ScienceDirect and indexed in Scopus. The paper explores how governance frameworks can support the responsible use of artificial intelligence in genomic medicine, especially as healthcare institutions move from innovation to clinical application. Read the full paper here: https://www.sciencedirect.com/science/article/pii/S2666521226000232 #ScienceDirect #Scopus #Artificial_Intel

I am pleased to share my Scopus-indexed article titled: “AI-driven genomic medicine: A comprehensive review of clinical applications, institutional dynamics, and governance challenges.” The article discusses how artificial intelligence is transforming genomic medicine, precision healthcare, clinical decision-making, and institutional practice. It also highlights why responsible governance, ethics, patient safety, and clinical reliability are essential as healthcare institutio

I am pleased to share my paper titled “Governance Frameworks for AI-Driven Genomic Medicine: From Innovation to Responsible Clinical Adoption.” The paper focuses on how healthcare institutions can develop responsible governance models for AI-driven genomic medicine, balancing innovation with patient safety, ethics, accountability, and clinical reliability. Read the full paper here: .https://papers.ssrn.com/sol3/papers.cfm?abstract_id=6725678 #AI_Governance #Genomic_Medicine #